Veraxa Biotech AG Warrants
VRXAW
26 hedge funds and large institutions have $993K invested in Veraxa Biotech AG Warrants in 2026 Q2 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
67.48% more ownership
Funds ownership: 0% → 67.48% (+67%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
+$282K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$192K |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$186K |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$172K |
| 5 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$154K |
Top Sellers
VRXAW Hedge Fund Activity: Q2 2026 in Review
26 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Veraxa Biotech AG Warrants (VRXAW) for Q2 2026, worth a combined $993K.
Buyers outnumbered sellers: 26 funds opened new VRXAW positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was CSS LLC, opening a new position worth an estimated $282K.
- 26 institutional investors held Veraxa Biotech AG Warrants (VRXAW) as of Q2 2026, up from 0 in Q1 2026.
- Funds reported $993K of Veraxa Biotech AG Warrants stock for Q2 2026.
- 26 funds opened new Veraxa Biotech AG Warrants positions in Q2 2026 and 0 closed out, a net change of +26 holders.
- The largest Veraxa Biotech AG Warrants buyer in Q2 2026 was CSS LLC, an estimated $282K added.
Based on aggregated 13F filings for Q2 2026.